RLYP is good for developing one product to lure good big company to take over. But it is now changing its mind as to try to develop to sell the drug itself. That is very dangerous and cause big sell off. The drug can get fda approve doesn't mean it can sell good. May be the sample they took for passing the drug test and get fda approve doesn't it can sell good and make money.
It has wrong approach. Why? Because it is not in a company the size of a country and trying to do the job as one. Trying to be the best among the best academically, the company has to be as big as USA or China! AZN is big but far away from being big enough!